peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

antimicrobial peptide

Omiganan

Published evidence · coverage incomplete

Anatomy in the research

Anatomy evidence is still being assembled.

These are anatomical mentions in cited research—not established treatment targets or proof of benefit in people.

This publication has no anatomy passages that meet our source-linking checks yet. Read the available findings ↓

General anatomy view only. No peptide-specific structures are highlighted.

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

How does it work?

Target, response, and disposition.

Pharmacokinetics

In an HPLC physicochemical assay at 0.4 mM, the retention time value for CHEMBL1615933 was not provided.

Sources[1]chembl-activitiesChEMBL activities for CHEMBL1615933Molecule: CHEMBL1615933 Target: No relevant target (CHEMBL2362975) Assay: Retention time of the compound at 0.4 mM by HPLC analysis Assay format: small-molecule physicochemical format Standard result: Retention_time not reported Document: CHEMBL4229348
Reported result
Retention_time not reported
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Molecule: CHEMBL1615933 Target: No relevant target (CHEMBL2362975) Assay: Retention time of the compound at 0.4 mM by HPLC analysis Assay format: small-molecule physicochemical format Standard result: Retention_time not reported Document: CHEMBL4229348”

    ChEMBL activities for CHEMBL1615933 · Activity 18656273

    chembl-activities:chembl1615933:6f4c7b64ac51:6f4c7b64ac51

What has been studied?

What the evidence says.

Study findings

Using CLSI broth microdilution after overnight incubation, the minimum inhibitory concentration (MIC) of CHEMBL1615933 against fluconazole-resistant Candida albicans ATCC 64550 was 50000.0 nM.

Sources[1]chembl-activitiesChEMBL activities for CHEMBL1615933Molecule: CHEMBL1615933 Target: Candida albicans (CHEMBL366) Assay: Antifungal activity against fluconazole-resistant Candida albicans ATCC 64550 after overnight incubation by CLSI broth microdilution method Assay format: organism-based format Standard result: MIC = 50000.0 nM Document: CHEMBL4229348
Reported result
MIC = 50000.0 nM
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Molecule: CHEMBL1615933 Target: Candida albicans (CHEMBL366) Assay: Antifungal activity against fluconazole-resistant Candida albicans ATCC 64550 after overnight incubation by CLSI broth microdilution method Assay format: organism-based format Standard result: MIC = 50000.0 nM Document: CHEMBL4229348”

    ChEMBL activities for CHEMBL1615933 · Activity 18656347

    chembl-activities:chembl1615933:6f4c7b64ac51:6f4c7b64ac51

Study findings

In a microbroth dilution test measured after 48 hrs, the minimum inhibitory concentration (MIC) for CHEMBL1615933 against vancomycin-resistant Enterococcus faecium was 2.0 ug.mL-1.

Sources[1]chembl-activitiesChEMBL activities for CHEMBL1615933Molecule: CHEMBL1615933 Target: Enterococcus faecium (CHEMBL357) Assay: Antibacterial activity against Vancomycin-resistant Enterococcus faecium assessed as reduction in bacterial growth measured after 48 hrs by microbroth dilution method Assay format: organism-based format Standard result: MIC = 2.0 ug.mL-1 Document: CHEMBL5230081
Reported result
MIC = 2.0 ug.mL-1
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “Molecule: CHEMBL1615933 Target: Enterococcus faecium (CHEMBL357) Assay: Antibacterial activity against Vancomycin-resistant Enterococcus faecium assessed as reduction in bacterial growth measured after 48 hrs by microbroth dilution method Assay format: organism-based format Standard result: MIC = 2.0 ug.mL-1 Document: CHEMBL5230081”

    ChEMBL activities for CHEMBL1615933 · Activity 24992123

    chembl-activities:chembl1615933:6f4c7b64ac51:6f4c7b64ac51

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, identity, interaction, mechanism, regulatory, safety
  • 26 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (17), assurance_score_below_0.72 (8), current_regulatory_source_required (6), extraction_ambiguity (28), high_risk_requires_regulatory_or_two_independent_sources (8), no_direct_support (23)
  • A source-backed introductory overview is not yet available.

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. ChEMBL activities for CHEMBL1615933 ↗

    chembl-activities · published 2026-08-28 · retrieved 2026-08-28T12:35:21Z

Publication history and provenance

Version 1 · Automated assessment · 2026-08-28T12:35:21Z

b70967eacc2f48bac409e9b8c961cdb18bbf107ef503d66b2907a14edb92027a